Condition 101 About Large-Cell Immunoblastic Lymphoma

What are the alternative names for Large-Cell Immunoblastic Lymphoma?

  • Large cell immunoblastic lymphoma

Top Global Doctors For Large-Cell Immunoblastic Lymphoma

View All Doctors

Latest Advances On Large-Cell Immunoblastic Lymphoma

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.

Clinical Trials For Large-Cell Immunoblastic Lymphoma

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 25
  • Start Date: December 2020
A Multicenter Phase 2 Study of Belantamab Mafodotin in Relapsed or Refractory Plasmablastic Lymphoma and ALK+ Large B-cell Lymphoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug, Biological
  • Participants: 40
  • Start Date: February 4, 2019
A Phase 1/2 Study of Pembrolizumab Plus Pralatrexate for Treatment of Relapsed or Refractory Peripheral T-Cell Lymphomas
View All Clinical Trials